000			01591nam a2200433 a 4500
005			20250913111645.0
008			981208s1983 xxu 00 eng b
010			_a82-17591
020			_a0806712716 _cpbk.
035			_a82697
039		9	_y08-18-1999 _zload
090			_aQV150.C386 1981 9 [00002148075]
090			_aQV150 / QV150
245	1	0	_aCa 2+ entry blockers, adenosine, and neurohumors _cedited by Gary F. Merrill, Harvey R. Weiss
260			_aBaltimore-Munich _bUrban and Schwarzenberg _c1983
300			_axvii, 328 p. : ill. ; 23 cm.
590			_a2
650			_aCardiovascular system _xPhysiology _xCongresses
650			_aNeuroregulators _xPhysiology _xCongresses
650			_aCardiovascular system _xEffect of drugs on
650			_aAdenosine _xPhysiological effect
650			_aCatecholamines _xPhysiological effect
650			_aAdenosine _xPhysiology _xCongresses
650			_aCalcium antagonists, Exogenous _xPharmacodynamics _xCongresses
650			_aCardiovascular agents _xCongresses
650			_aCardiovascular System _xDrug effects _xCongresses
650			_aCardiovascular systems _xPhysiology _xCongresses
700	1		_aWeiss, Harvey R
700	1		_aMerrill, Gary F
740			_aCa two plus entry blockers, adenosine, and neurohumors
907			_a.b10283729 _b2021-05-28 _c2019-11-12
942			_c01 _n0 _kQV150.C386 1981 9 [00002148075]
914			_avtls000029624
991			_aFakulti Perubatan
991			_aFakulti Perubatan
998			_ad _b1999-05-08 _cm _da _feng _gxxu _y0 _z.b10283729
999			_c30371 _d30371